AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GENETIC SIGNATURES LTD

0.070

+0.0046.06%

Volume:118.66K

Turnover:8K

Market Cap:15.90M

PE:-1.13

High:0.070

Open:0.068

Low:0.067

Close:0.066

52wk High:0.430

52wk Low:0.051

Shares:227.14M

Float Shares:188.02M

Volume Ratio:1.20

T/O Rate:0.06%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.062

EPS(LYR):-0.062

ROE:-32.64%

ROA:-17.27%

PB:0.45

PE(LYR):-1.13

Loading ...

Overview Company News Filings

Concept

Novel Coronavirus Treatment-0.88%

Capital Flow

Inflow:

Outflow:

News

Genetic Signatures - General Meeting for Considering Resolution That Individual be Removed as Director of Co

THOMSON REUTERS

Genetic Signatures - Received a Request from BCAL Diagnostics for Directors of Gss to Call and Arrange General Meeting of Shareholders

THOMSON REUTERS

BCAL Diagnostics - Requests Removal of Michael Aicher and Appointment of Forrester and Melki to Gss Board

THOMSON REUTERS

Genetic Signatures - Requested BCAL Diagnostics to Clarify Details of Its Shareholdings and Associates in Gss

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigermarketf.com/stock/GSS.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GSS.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"GSS.AU\",,,,,undefined,":{"symbol":"GSS.AU","market":"AU","secType":"STK","nameCN":"GENETIC SIGNATURES LTD","latestPrice":0.07,"timestamp":1789711920000,"preClose":0.066,"halted":0,"volume":118656,"delay":0,"changeRate":0.060606060606060656,"nameEN":"GENETIC SIGNATURES LTD","floatShares":188016272,"shares":227138828,"eps":-0.0617,"marketStatus":"Not Yet Opened","change":0.004,"latestTime":"09-18 16:12:00 AEST","open":0.068,"high":0.07,"low":0.067,"amount":8244,"amplitude":0.045455,"askPrice":0.074,"askSize":20000,"bidPrice":0.068,"bidSize":30000,"shortable":3,"etf":0,"ttmEps":-0.0617,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789948800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.066,"openAndCloseTimeList":[[1789689600000,1789711200000]],"volumeRatio":1.2025856569454898,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"GSS.AU","preClose":0.073,"auctionPrice":0.072,"auctionVolume":36833,"auction":3,"marketStatus":"盘后竞价","timestamp":1789625107047}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"GSS.AU\",,,,,undefined,":{"symbol":"GSS.AU","floatShares":188016272,"roa":"-17.27%","roe":"-32.64%","lyrEps":-0.0617,"volumeRatio":1.2025856569454898,"shares":227138828,"dividePrice":0,"high":0.07,"amplitude":0.045455,"preClose":0.066,"low":0.067,"week52Low":0.051,"pbRate":"0.45","psRate":"0.82","week52High":0.43,"institutionHeld":0,"latestPrice":0.07,"committee":0.2,"eps":-0.0617,"divideRate":0,"volume":118656,"delay":0,"ttmEps":-0.0617,"open":0.068,"prevYearClose":0.25,"prevWeekClose":0.08,"prevMonthClose":0.095,"prevQuarterClose":0.067,"fiveDayClose":0.08,"twentyDayClose":0.068,"sixtyDayClose":0.058,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSS.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787616000000,"name":null,"time":"","dateTimestamp":1787580000000,"actualEps":null},{"date":"2026-02-26","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772060400000,"name":null,"time":"","dateTimestamp":1772024400000,"actualEps":null},{"date":"2025-08-25","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756080000000,"name":null,"time":"","dateTimestamp":1756044000000,"actualEps":null},{"date":"2025-02-26","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"market":"AU","date":"2023-12-27","symbol":"GSS.AU","defaultRemindTime":1703631600000,"type":"split","dateTimestamp":1703595600000,"forFactor":976761,"toFactor":1000000,"ratio":0.9767610000000001}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSS.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSS.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668931922","title":"Genetic Signatures - General Meeting for Considering Resolution That Individual be Removed as Director of Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2668931922","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668931922?lang=en_us&edition=fundamental","pubTime":"2026-09-17 07:50","pubTimestamp":1789602626,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nFWN4580MU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GSS.AU","BK7048","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668319279","title":"Genetic Signatures - Received a Request from BCAL Diagnostics for Directors of Gss to Call and Arrange General Meeting of Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2668319279","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668319279?lang=en_us&edition=fundamental","pubTime":"2026-09-17 07:50","pubTimestamp":1789602626,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nFWN4580MU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GSS.AU","BK7501","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664236888","title":"BCAL Diagnostics - Requests Removal of Michael Aicher and Appointment of Forrester and Melki to Gss Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2664236888","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664236888?lang=en_us&edition=fundamental","pubTime":"2026-09-03 10:40","pubTimestamp":1788403215,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUEV0GFX:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BDX.AU","BK7501","BK7048","GSS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664842699","title":"Genetic Signatures - Requested BCAL Diagnostics to Clarify Details of Its Shareholdings and Associates in Gss","url":"https://stock-news.laohu8.com/highlight/detail?id=2664842699","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664842699?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:38","pubTimestamp":1788392299,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44U16O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","GSS.AU","BDX.AU","BK7048","BK7501"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":8,"pageCount":1,"totalSize":32,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/GSS.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Novel Coronavirus Treatment","id":"package_au_concept_xgzlg","bkCode":"BK7501","changeRate":-0.008804}]}}